Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > 20% of all Global Deaths ?

<< Previous

Bullboard Posts

Next >>

Comment by pm1861on Jul 26, 2022 8:09am

216 Views

Post# 34850351

RE:RE:RE:RE:RE:20% of all Global Deaths ?

Hey SM,

Long time follower of this board and investor. The EUPHRATES trial ( for which the current confirmatory TIGRIS trial is based) was the first randomized, controlled and blinded study for the treatment of endotoxic septic shock. Studies up to this point were smaller and not as robust. That is why this current open label, bayesian confirmatory trial which builds on EUPHRATES is such a big deal.

See the link for a great article by Claudio Ronco

https://ccforum.biomedcentral.com/articles/10.1186/cc13912

PM

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?